Tocilizumab treatment in COVID‐19: A single center experience
Abstract Tocilizumab (TCZ), a monoclonal antibody against interleukin‐6 (IL‐6), emerged as an alternative treatment for COVID‐19 patients with a risk of cytokine storms recently...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,281
- Institution
- Huazhong University of Science and Technology
External Links
Identifiers
- ORCID
- 0000-0002-3923-2111
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.